Industry News
Genea stem cells approved in UK
The UK Stem Cell Bank (UKSCB) has approved 84 human embryonic stem cell (hESC) lines from Genea Biocells for research in the UK.
[ + ]RV Investigator welcomed to port
The research vessel Investigator was officially commissioned into service on Friday by Minister for Industry Ian Macfarlane. At a welcome-to-port ceremony, held on the CSIRO Wharf at Battery Point, Hobart, the vessel was handed over from CSIRO to the Marine National Facility for operation. [ + ]
Lonza announces collaborations and pilot study results
Life sciences company Lonza has announced collaboration agreements with two prominent innovation clusters in France and Italy, as well as the publication of two early pilot studies conducted in tandem with Lipogen. [ + ]
Potential hepatitis B cure hits trial stage
The Walter and Eliza Hall Institute and partner TetraLogic Pharmaceuticals have commenced a phase I/IIa trial of a new drug showing promise as a cure for hepatitis B.
[ + ]Vale Don Metcalf AC
The life sciences community is saddened by the death of Professor Donald Metcalf AC on 15 December 2014 at the age of 85.
[ + ]NFMRI awards 2015 grants
The National Foundation for Medical Research and Innovation (NFMRI), with the support of the NSW Department of Primary Industries (DPI), this week congratulated its 2015 grant recipients at an awards ceremony held at the MLC Centre, Sydney. [ + ]
Inaugural industry report released
The Australian Industry Report 2014 has been released by the Department of Industry's Office of the Chief Economist. Providing an overview and analysis of the major economic factors affecting Australia's industries, the focus of this year's inaugural report is structural change.
[ + ]Plan B and the MRFF
The federal government has revised its GP co-payment plan along with the funding mechanism for the proposed Medical Research Future Fund.
[ + ]Imugene completes $3.5m capital raising
Imugene (ASX:IMU) has completed a second placement and SPP to take the total value of its capital raising to $3.5m. Proceeds will be used in part to fund HER-Vaxx trials in gastric cancer.
[ + ]Malaria on the decline
Good news: the number of people dying from malaria has fallen dramatically since 2000, according to the World Malaria Report 2014. [ + ]
New agricultural and environmental sciences precinct
The Australian National University and CSIRO have formed a new collaborative science precinct. [ + ]
Join the Australian pavilion at the China Medical Equipment Fair
AusBiotech seeks your expression of interest to join the Australian delegation to the 73rd China International Medical Equipment Fair (CMEF) in May 2015. It is said to be the Asia-Pacific's largest exhibition, with around 2700 exhibitors and 80,000 visitors.
[ + ]Orthocell enters bone repair partnership
Orthocell (ASX:OCC) has signed a deal to develop bone repair products combining technology from the company and from Bonesupport.
[ + ]Phosphagenics gets ethics nod for its pain patch trial
Phosphagenics (ASX:POH) has won ethics approval for a proof-of-concept phase II trial of its TPM/Oxycodone patch in neuropathic pain.
[ + ]Cell death and skin disease
Abnormal activation of cell death pathways may cause inflammatory skin diseases such as psoriasis. [ + ]
